BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Angiogenesis
,
Lung cancer
,
Stem cell
,
Biofuel
,
Rosiglitazone
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD20
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
B lymphocyte (naive) of spleen
Spleen
B lymphocyte (IgM memory) of spleen
Lymph nodes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disorder of lung
Common variable immunodeficiency
Infection due to Mycobacterium abscessus
Sjögren's syndrome
Infection due to Citrobacter
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
iodine-131 anti-B1 antibody
rituximab
Platelet Factor 4
naphthalene
X-Rays
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NCSTN
BECN1
TNFRSF9
IL10RB
CD247
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing …
Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expre…
Identity thieves: T cells steal CD20 from B cells but mark themselves for certain death.
Engineering CD20 CARs with a Twist.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
HBV Reactivation in Anti CD20 Treatment
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma
Optimizing HBV Management During Anti-CD20 Antibodies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ